Clinical Trials
3 trialsNCT01507545 2022-05-06
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
Morphotek
Phase 2 Terminated
NCT01335009 2021-09-01
Efficacy Study of Pharmacokinetic(PK)/Pharmacodynamic(PD) Relationship of Monotherapy MORAb-004 in Metastatic Melanoma
Eisai Inc.
Phase 2 Completed
NCT01574716 2019-08-21
SOURCE
Morphotek
Phase 2 Completed